Infectious disease testing of UK-bound refugees: a population-based, cross-sectional study

Table 6 Hepatitis C yield in tested applicants compared to country prevalence estimates, where available, by country of nationality

Country of nationality	Number screened (n)	Number of cases detected (%)	Yield in tested cohort, % (95% CI)	Estimated prevalence, % (95% CI) [19, 20]^a
Afghanistan	57	1 (1.75)	1.75 (0.24–11.61)	1.1 (0.40–1.92)
Democratic Republic of Congo	499	4 (0.80)	0.80 (0.30–2.12)	4.3 (3.2–13.7)^b
Eritrea	54	0	0.0	N/A
Ethiopia	250	1 (0.40)	0.40 (0.06–2.79)	0.96 (0.60–1.20)
Iran	14	1 (7.14)	7.14 (0.92–38.84)	0.5 (0.20–1.00)
Iraq	517	0	0.0	0.40 (0.30–0.50)
Palestine	28	0	0.0	N/A
Somalia	382	1 (0.26)	0.26 (0.04–1.84)	N/A
South Sudan	40	0	0.0	N/A
Sudan	361	1 (0.28)	0.28 (0.04–1.94)	N/A
Syria	6994	29 (0.41)	0.41 (0.29–0.60)	2.80 (0.60–)
Uganda	2	0	0.0	N/A
Other AFR^c	8	0	0.0
Other EMR^d	9	0	0.0
Other EUR^e	5	0	0.0
Other WPR^f	3	0	0.0
Total	9223	38 (0.41)	0.41 (0.30–0.57)

WHO regional estimates: AFR: 1.0% (0.7–1.6%); EMR: 2.3% (1.9–2.4%); EUR: 1.5% (1.2–1.5%); WPR: 0.7% (0.6–0.8%) [40]
^aData from Polaris Observatory HCV Collaborators, 2017 [20] unless otherwise stated. Yield was calculated on adults aged 15 years and older, for ethical reasons and consistency
^bData source from Gower et al. 2014 [19]
^cOther AFR included Burundi, Congo, Rwanda, Cameroon, Nigeria
^dOther EMR included Jordan, Lebanon, Djibouti, Yemen, Pakistan
^eOther EUR included UK, St Helena, Switzerland, Turkey
^fOther WPR included Solomon Islands, China, Taiwan or applicants with no nationality specified
CI confidence interval

ISSN: 1741-7015